GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shandong WIT Dyne Health Co 000915.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

19.80

+1.33%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥2.23bn

FY2016FY2025

Net income

CN¥535.1m

FY2016FY2025

Free cash flow

CN¥1.22bn

FY2016FY2025

Shareholders' equity

CN¥2.86bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥2.23bnCN¥2.13bnCN¥2.48bnCN¥2.34bnCN¥2.03bnCN¥1.82bnCN¥1.80bnCN¥1.53bnCN¥1.77bnCN¥1.54bn
Gross profitCN¥1.90bnCN¥1.74bnCN¥2.15bnCN¥1.84bnCN¥1.40bnCN¥1.10bnCN¥1.06bnCN¥921.0mCN¥1.19bnCN¥931.3m
Research and developmentCN¥91.1mCN¥101.5mCN¥95.6mCN¥65.6mCN¥82.1mCN¥121.2mCN¥127.6mCN¥42.7mCN¥40.8mCN¥58.8m
Operating incomeCN¥1.19bnCN¥1.18bnCN¥1.33bnCN¥1.16bnCN¥818.1mCN¥612.7mCN¥414.2mCN¥270.7mCN¥527.6mCN¥423.8m
Net incomeCN¥535.1mCN¥515.6mCN¥585.3mCN¥526.9mCN¥380.3mCN¥290.8mCN¥204.1mCN¥129.7mCN¥243.2mCN¥198.4m
Diluted earnings per share2.282.202.502.251.641.230.870.551.050.85

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥5.00bnCN¥4.93bnCN¥5.20bnCN¥4.69bnCN¥3.94bnCN¥3.69bnCN¥3.15bnCN¥2.90bnCN¥2.78bnCN¥2.48bn
Cash and short-term investments—CN¥3.08bnCN¥3.26bnCN¥2.79bnCN¥1.95bnCN¥1.49bnCN¥979.9mCN¥1.01bnCN¥706.9mCN¥617.6m
Total liabilitiesCN¥647.5mCN¥518.5mCN¥701.7mCN¥629.0mCN¥536.0mCN¥759.7mCN¥585.3mCN¥558.9mCN¥556.4mCN¥532.9m
Debt—CN¥2.9mCN¥66,955CN¥7.9mCN¥9.0mCN¥29.9mCN¥20.0mCN¥20.0mCN¥21.0mCN¥40.5m
Shareholders' equityCN¥2.86bnCN¥2.91bnCN¥2.98bnCN¥2.58bnCN¥2.24bnCN¥1.95bnCN¥1.73bnCN¥1.60bnCN¥1.50bnCN¥1.28bn
Shares outstanding234m234m234m234m232m237m235m238m232m232m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.27bnCN¥929.6mCN¥1.17bnCN¥1.20bnCN¥755.9mCN¥735.6mCN¥243.5mCN¥538.6mCN¥426.1mCN¥500.9m
Capital spending−CN¥48.3m−CN¥43.6m−CN¥50.6m−CN¥89.7m−CN¥120.3m−CN¥101.8m−CN¥172.5m−CN¥131.5m−CN¥177.8m−CN¥229.8m
Free cash flowCN¥1.22bnCN¥886.0mCN¥1.12bnCN¥1.11bnCN¥635.5mCN¥633.8mCN¥71.1mCN¥407.1mCN¥248.3mCN¥271.1m
Dividends paid−CN¥585.8m−CN¥585.8m−CN¥690.9m−CN¥339.7m−CN¥105.2m−CN¥70.3m−CN¥70.3m−CN¥52.4m−CN¥28.5m−CN¥22.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥436.1mCN¥412.3mCN¥625.8mCN¥432.1mCN¥554.2mCN¥616.3mCN¥756.5mCN¥223.6m
Gross profitCN¥361.8mCN¥337.5mCN¥543.3mCN¥349.2mCN¥470.3mCN¥531.9mCN¥586.9mCN¥165.8m
Operating incomeCN¥203.6mCN¥232.4mCN¥329.3mCN¥139.7mCN¥342.7mCN¥406.7mCN¥358.5mCN¥73.7m
Net incomeCN¥112.8mCN¥110.6mCN¥127.0mCN¥70.6mCN¥155.1mCN¥182.3mCN¥150.2mCN¥33.6m
Diluted earnings per share0.480.470.540.300.660.780.640.14
Cash from operations———CN¥280.0mCN¥620.0mCN¥54.0mCN¥371.0mCN¥148.0m
Capital spending—−CN¥19.0m−CN¥9.0m−CN¥3.0m−CN¥25.0m−CN¥10.0m−CN¥22.0m−CN¥1.0m
Free cash flow———CN¥277.0mCN¥595.0mCN¥44.0mCN¥349.0mCN¥147.0m
Total assetsCN¥4.14bnCN¥4.95bnCN¥5.00bnCN¥4.78bnCN¥4.60bnCN¥5.16bnCN¥4.93bnCN¥4.57bn
Cash and short-term investments———CN¥3.05bnCN¥2.77bnCN¥3.12bnCN¥3.08bnCN¥2.72bn
Debt——————CN¥2.9m—
Shareholders' equityCN¥2.62bnCN¥2.97bnCN¥2.86bnCN¥2.85bnCN¥2.78bnCN¥3.09bnCN¥2.91bnCN¥2.76bn

Financial ratios

Data as of 10 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin85.1%81.7%86.3%78.5%68.9%60.7%—
Operating margin53.6%51.8%50.6%48.4%38.3%31.0%—
Net margin24.0%24.2%23.6%22.5%18.8%16.0%—
Return on equity18.7%17.7%19.6%20.4%16.9%14.9%—
Return on assets10.7%10.5%11.3%11.2%9.7%7.9%—
Free cash flow yield23.3%17.1%21.6%22.7%15.6%14.6%—
Revenue growth4.4%-14.1%6.1%15.5%11.3%1.2%—
Earnings growth3.8%-11.9%11.1%38.6%30.8%42.5%—
Current ratio6.58x8.40x6.25x5.89x5.42x3.43x—
Debt to equity—0.00x0.00x0.00x0.00x0.02x0.01x
Equity ratio57.2%59.0%57.4%55.1%57.0%52.8%—
Interest coverage—2190.84x2167.11x2159.62x1782.26x818.90x319.00x
R&D as a share of sales4.1%4.8%3.8%2.8%4.1%6.7%—
Buybacks as a share of market value0.0%-0.0%0.0%-1.1%2.2%-1.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.6%4.1%6.1%
Operating income0.9%14.3%15.2%
Net income0.5%13.0%13.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin83.5%83.0%77.7%71.8%
Operating margin54.4%52.9%48.2%39.3%
Net margin24.1%23.5%21.7%18.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.512.811.620.218.619.130.427.128.738.0
Price to sales3.53.12.74.53.53.03.52.34.04.9

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 1 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year2.002.502.500.800.800.350.300.30
  • 13-for-10 split · 16 Jun 2017
  • 17-for-10 split · 27 Sept 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.